Vatelizumab

Vatelizumab · Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vatelizumab, covering 2016-12-21 to 2016-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 [Phase 2]